Based upon the circumstances of that time frame and the situation as it was, I don't categorize those actions as having been mistakes. The justifications for those actions were fairly sound at the time, and it cannot possibly be determined that that either the option repricing or the RS for NASDAQ had a negative impact on the trajectory of the company. Maybe if not for NASDAQ, we could be sitting at 3 cents instead of around 60 cents - who knows. Just like at the time, it could not have been known that fundraising would remain an issue despite the "respectability" of being a NASDAQ listed company.
Among the strengths we do have is our patent portfolio. If we had lost Mr. Brar to a competitor, would it be nearly as complete? Again, impossible to tell because that alternate timeline did not occur. But the continuing stream of patent approvals remains an occasional bright flicker on our radar screen. Maybe that's what keeps us from falling to three cents. And if he stayed because of option repricing to $3, that certainly hasn't cost investors a penny at this point; it has no cost until they exercise those options. So clearly, option repricing did not put us down here, and therefore the continuous harping on this topic is not substantiated by logic.
As for your other post/question regarding bonuses, I will say that as an investor, I would tie the potential for bonuses to the performance of my investment. If/when my investment becomes profitable, I might be inclined to consider bonuses commensurate with the stock performance, but I would bear in mind that their performance bonus is already built in to their compensation via the aforementioned options. Until then, I think their salaries will have to be sufficient.
All just my opinion, of course...
Message in reply to:
I’m asking because I’d like to know if you and other misguided investors would make the same mistakes again. I’m not looking forward to more bad decisions by management and my fellow shareholders.
